Kindstar Globalgene Technology, Inc. (Kindstar Global) announced on 7 May 2026 that all partners have unanimously approved amendments to the existing partnership agreement originally disclosed on 12 November 2023. The revisions extend both the duration and financial framework of the partnership formed on 20 December 2023.

The partnership’s overall term is now scheduled to conclude on 8 May 2029. Within this horizon, the investment period has been lengthened from two to three years, running from 8 May 2024 to 8 May 2027. A two-year payback period will follow, maintaining the original structure but shifting the timeline to 8 May 2029. With unanimous partner consent, the combined investment and payback periods may be further prolonged, subject to a hard cap of six years in total.

To accommodate the additional investment year, the partners agreed that the management fee for the third year will mirror the payback-period standard: an annual charge equal to 1.5% of the fund’s total cost of remaining investments calculated at the preceding year-end.

No other clauses in the original partnership agreement have been modified.